Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002348 · ClinicalTrials.gov registry record · Phase 2
A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma
A Phase 2 study, sponsored by Genzyme, a Sanofi Company.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002348: Completed Phase 2 study, sponsored by Genzyme, a Sanofi Company.
NCT00002348 is a Phase 2 study that has completed, run by Genzyme, a Sanofi Company. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002348, a Phase 2 study, has completed, sponsored by Genzyme, a Sanofi Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
To estimate the response rate, response duration, clinical benefit, and toxicity of mitoguazone dihydrochloride (MGBG) in patients with AIDS-related refractory or relapsing non-Hodgkin's lymphoma (NHL).
Interventions
- DRUG Mitoguazone
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 2 |
What the finished NCT00002348 record still lists
NCT00002348 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Mitoguazone is the first listed.
NCT00002348 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002348 about?
NCT00002348 is a clinical study titled "A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma". To estimate the response rate, response duration, clinical benefit, and toxicity of mitoguazone dihydrochloride (MGBG) in patients with AIDS-related refractory or relapsing non-Hodgkin's lymphoma (NHL).
What is the current status of trial NCT00002348?
This trial is currently completed. It is a Phase 2 study.
What interventions are being tested in trial NCT00002348?
The interventions under investigation include: Mitoguazone (DRUG).
Who is sponsoring clinical trial NCT00002348?
This trial is sponsored by Genzyme, a Sanofi Company, which has 196 total clinical trials registered on ClinicalTrials.gov.